FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039186 [Registered on: 05/01/2022] Trial Registered Prospectively
Last Modified On: 30/12/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   leprosy ulcers and bacterial infections 
Scientific Title of Study   To evaluate antibiogram and occurrence of bacterial biofilm in leprosy plantar ulcers 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Michelle Serene Fernandes 
Designation  Associate Professor 
Affiliation  Father Muller Medical College 
Address  Department of dermatology, Fr Muller Medical College, Kankanady Mangalore
Dept of Dermatology, Fr Muller Road Kankanady P.O Mangalore
Dakshina Kannada
KARNATAKA
575002
India 
Phone  09980785447  
Fax    
Email  michelle@fathermuller.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Michelle Serene Fernandes 
Designation  Associate Professor 
Affiliation  Father Muller Medical College 
Address  Department of Dermatology, Fr Muller Medical college Kankanady Mangalore
Dept of Dermatology, Fr Muller Road Kankanady P.O Mangalore
Dakshina Kannada
KARNATAKA
575002
India 
Phone  09980785447  
Fax    
Email  michelle@fathermuller.in  
 
Details of Contact Person
Public Query
 
Name  Dr Michelle Serene Fernandes 
Designation  Associate Professor 
Affiliation  Father Muller Medical College 
Address  Department Of Dermatology Fr Muller medical College Mangalore
Dept of Dermatology, Fr Muller Road Kankanady P.O Mangalore
Dakshina Kannada
KARNATAKA
575002
India 
Phone  09980785447  
Fax    
Email  michelle@fathermuller.in  
 
Source of Monetary or Material Support  
Indian Association of Dematologists, Venereologists and Leprologists (IADVL) research grant 
 
Primary Sponsor  
Name  IADVL research grant 
Address  Indian Association of Dermatologists, Venereologists and Leprologists, 314-315 3rd Floor KM Trade Tower, H3, Sector 14, Kaushambi, Ghaziabad, Uttar Pradesh - 201010 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Michelle Fernandes  Father Muller Medical College Hospital  Skin OPD 65, Fr Muller Medical College Hospital, Fr Muller Road Kankanady P.O Mangalore 575002
Dakshina Kannada
KARNATAKA 
09980785447

michelle@fathermuller.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
FatherMuller Institutional Ethics Committee (FMIEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details 
a) Leprosy patients with plantar ulcers who are not on topical or systemic antibiotics since atleast 2 weeks
b) Age above 18 years 
 
ExclusionCriteria 
Details  a. patients with a history of use of topical or systemic antibiotics within 2 weeks.
b. Patients with ulcer who are admitted in hospital since atleast 5 days which can alter bacterial colonization  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Quantitative
measurement of biofilm production by the Microtitre plate method (MTP) will be performed for in clinical isolates of bacteria. An optical
density (OD) greater than 0.240 indicated a strong biofilm producer, an OD
between 0.120–0.240 a moderate biofilm producer and an OD of less than 0.120,
a non-biofilm producer. S. aureus ATCC 25923 will be used as the control
organism for biofilm production
 
3 days 
 
Secondary Outcome  
Outcome  TimePoints 
The antimicrobial susceptibility testing (AST) determined by the Kirby-Bauer
disc diffusion method after it is incubated for 18–24 h at 37 °C aerobically, the
isolates will be classified as susceptible, intermediate and resistant as per standard
guidelines.  
24hrs 
 
Target Sample Size   Total Sample Size="65"
Sample Size from India="65" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Sixty-five leprosy patients with plantar ulcers attending Dermatology OPD over 24 months period will be enrolled after obtaining informed consent. Swabs will be collected from Plantar ulcers. Isolation and identification of bacteria will be performed, based on culture and standard bacterial identification methods. Antimicrobial susceptibility testing will be conducted using the disk diffusion test. Detection of biofilm production will be carried out using the Micro Titre Plate method (MTP). The pattern of antibiotic resistance exhibited by biofilm-producers will be compared with non-biofilm-producers.

 
Close